The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hackman Jeffrey S. since 2022.
This trader's CIK number is 1926254.
At the time of last reporting, Hackman Jeffrey S. was the Chief Executive Officer of Fennec Pharmaceuticals Inc.. (stock ticker symbol FENC).
Also see all insider trading activities at Fennec Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | FENC | 15,000 | $104,601 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | CMRA | 47,600 | $98,056 | 0 | $0 | 0 | $0 |
1. Fennec Pharmaceuticals Inc. (FENC)
2. Comera Life Sciences Holdings, Inc. (CMRA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-16 | FENC | Buy | 1,035 | 6.75 | 6,986 |
| 2025-05-19 | FENC | Buy | 13,965 | 6.99 | 97,615 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-09-09 | CMRA | Buy | 47,600 | 2.06 | 98,056 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hackman Jeffrey S. (Chief Executive Officer of Fennec Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.